Supplementary Figure S6 from Next-Generation Sequencing–Based MSI Scoring Predicts Benefit in Mismatch Repair–Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D
Authors:
- Jonathan D. SchoenfeldJSJonathan D. Schoenfeld
- Nilofer S. AzadNANilofer S. Azad
- Jacob GrossJGJacob Gross
- Li ChenLCLi Chen
- Michael J. OvermanMOMichael J. Overman
- Katrina KaoKKKatrina Kao
- Latifa JacksonLJLatifa Jackson
- Donna BrunnquellDBDonna Brunnquell
- Xiangning BuXBXiangning Bu
- Christina CoppolaCCChristina Coppola
- Ping GuanPGPing Guan
- Jennifer LeeJLJennifer Lee
Open Access
- 17 February 2025
- other
- Published by American Association for Cancer Research (AACR)